Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Group")
Investor Presentation
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound artificial intelligence (AI) software and simulation group, is pleased to announce that Stuart Gall, CEO, and Helen Jones, CFO, will provide a live presentation relating to Preliminary Results via the Investor Meet Company platform on Tuesday, 3rd May 2022 at 2:15pm BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Intelligent Ultrasound Group plc via: https://www.investormeetcompany.com/intelligent-ultrasound-group-plc/register-investor
Investors who already follow Intelligent Ultrasound Group plc on the Investor Meet Company platform will automatically be invited.
For further information, please contact:
Intelligent Ultrasound Group plc |
|
|||||||||
Stuart Gall, CEO |
Tel: +44 (0)29 2075 6534 |
|
||||||||
|
|
|
||||||||
Helen Jones, CFO |
|
|
||||||||
|
|
|
||||||||
|
|
|
||||||||
Cenkos Securities - Nominated Advisor and Broker |
Tel: +44 (0)20 7397 8900 |
|
||||||||
Giles Balleny / Max Gould (Corporate Finance) |
|
|
||||||||
Michael Johnson / Julian Morse (Sales) |
|
|
||||||||
|
|
|
||||||||
|
|
|
||||||||
|
|
|
||||||||
Walbrook PR |
Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com |
|
||||||||
Anna Dunphy / Paul McManus |
Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893 |
|
||||||||
|
|
|
|
|
|
|||||
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:
Simulation
Focusses on real-time hi-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,350 simulators have been sold to over 650 medical institutions around the world.
Clinical AI software
Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound guided needling and incorporates ScanNav Anatomy PNB.
NOTE: ScanNav Anatomy PNB is not yet available for sale in the US or any other territory requiring government approval for this type of product.